Director/PDMR Shareholding

RNS Number : 2280J

GlaxoSmithKline PLC

01 April 2015

 

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').

On 31 March 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.66 per Ordinary Share, and notional ADSs at a price of $46.80 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2015 to 31 March 2015:

Non Executive Director	Ordinary Shares	No. of ADSs
Sir Christopher Gent	3,991.060
Professor Sir Roy Anderson	458.972
Dr Stephanie Burns		486.201
Stacey Cartwright	339.240
Lynn  Elsenhans		1,103.464
Sir Philip Hampton	339.240
Judy Lewent		539.049
Sir Deryck Maughan		1,479.741
Dr Daniel Podolsky		1,109.806
Urs Rohner	339.240
Tom de Swaan	419.061
Jing Ulrich		306.518
Hans Wijers	339.240

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 April 2015

 

END

 

 

RDSEFLFBEZFBBBV